共 50 条
- [31] Outcome of hematopoietic stem cell transplantation (HCT) from HLA-matched related donor for Fanconi anemia (FA) in adolescents and adults: a retrospective study by Eastern Mediterranean Blood and Marrow Transplantation Group (EMBMT)Bone Marrow Transplantation, 2020, 55 : 1485 - 1490Ghuzayel AlDawsariAlaa ElhaddadRiad El FakihTarek Ben OthmanParvez AhmedArdeshir GhavamzadehAli BazarbachiMajed J. DasoukiGamal FathyHazzaa AlzahraniMohamed SamraLamia TorjemaneTariq Mahmood SattiMarwan ShaheenFeras AlfraihMouhab AyasAli AlahmariSaud AlhayliAmr NassarMiguel AbboudRaafat AbdelfattahHassan El SolhShahrukh HashmiTusneem ElhassanSyed Osman AhmedMahmoud Aljurf
- [32] Posttransplant Cyclophosphamide for Prevention of Graft-Versus-Host Disease after HLA-Matched Related and Unrelated Donor Peripheral Blood Stem Cell TransplantationBLOOD, 2014, 124 (21)Mielcarek, MarcoFurlong, TerrenceO'Donnell, Paul V.Storer, Barry E.Storb, Rainer F.Carpenter, Paul A.Martin, Paul J.
- [33] The impact of pre-existing HLA and red blood cell antibodies on transfusion support and engraftment in sickle cell disease after nonmyeloablative hematopoietic stem cell transplantation from HLA-matched sibling donors: A prospective, single-center, observational studyECLINICALMEDICINE, 2020, 24Nickel, Robert SheppardFlegel, Willy A.Adams, Sharon D.Hendrickson, Jeanne E.Liang, HuaTisdale, John F.Hsieh, Matthew M.
- [34] Post-Transplantation Cyclophosphamide for Prevention of Graft-Versus-Host Disease after HLA-Matched Related and Unrelated Donor Peripheral Blood Stem Cell TransplantationBIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S406 - S406Miekarek, MarcoFurlong, TerryO'Donnell, Paul V.Storer, Barry E.McCune, Jeannine S.Storb, Rainer F.Carpenter, Paul A.Flowers, Mary E. D.Appelbaum, Frederick R.Martin, Paul J.
- [35] Atorvastatin for the Prophylaxis of Acute Graft-versus-Host Disease in Patients Undergoing HLA-Matched Related Donor Allogeneic Hematopoietic Stem Cell Transplantation (allo-HCT)BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (01) : 71 - 79Efebera, Yvonne A.Geyer, SusanAndritsos, LeslieVasu, SumithiraJaglowski, SamanthaBingman, AnissaBlum, WilliamKlisovic, RebeccaHofmeister, Craig C.Benson, Don M.Penza, SamElder, PatrickCortright, KatieKitzler, RhondaCoombes, KevinO'Donnell, LynnDaneault, BethBradbury, HillaryZhang, JianyingChen, XilinGarman, SabrinaRanganathan, ParvathiYu, XueyanHofstetter, JessicaYu, JianhuaGarzon, RamiroScrape, Scott R.Lozanski, GerardDevine, Steven M.
- [36] T-Cell-Replete HLA-Haploidentical Hematopoietic Transplantation for Hematologic Malignancies Using Post-Transplantation Cyclophosphamide Results in Outcomes Equivalent to Those of Contemporaneous HLA-Matched Related and Unrelated Donor TransplantationJOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (10) : 1310 - 1316Bashey, AsadZhang, XuSizemore, Connie A.Manion, KarenBrown, StaceyHolland, H. KentMorris, Lawrence E.Solomon, Scott R.
- [37] One-Antigen Mismatched Related versus HLA-Matched Unrelated Donor Hematopoietic Stem Cell Transplantation in Adults with Acute Leukemia: Center for International Blood and Marrow Transplant Research Results in the Era of Molecular HLA TypingBIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (05) : 640 - 648Valcarcel, DavidSierra, JorgeWang, TaoKan, FangyuGupta, VikasHale, Gregory A.Marks, David I.McCarthy, Philip L.Oudshoorn, MachteldPetersdorf, Effie W.Ringden, OlleSetterholm, MichelleSpellman, Stephen R.Waller, Edmund K.Gajewski, James L.Marino, Susana R.Senitzer, DavidLee, Stephanie J.
- [38] Survival after T-Cell Replete Haploidentical Related Donor Hematopoietic Cell Transplantation (Haplo-HCT) Using Post-Transplant Cyclophosphamide (PT-CY) Compared with HLA-Matched Related Donor (MRD) Transplant for LymphomasBIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S75 - S76Karmali, ReemGhosh, NilanjanRocha, Vanderson G.Ahn, Kwang WooDiGilio, AlyssaArmand, PhilippeSalit, Rachel B.Fenske, Timothy S.Smith, Sonali M.Sureda, AnnaWagner-Johnston, NinaMeade, Javier BolanosHamadani, Mehdi
- [39] Influence of Graft Versus-Host Disease Prophylaxis Regimen On T-Cell Repertoire Diversity Following Reduced-Intensity HLA-Matched Unrelated Donor Allogeneic Hematopoietic Stem Cell TransplantationBLOOD, 2012, 120 (21)Salit, Rachel B.Hakim, Frances T.Bishop, Michael R.Friedman, Thea M.Korngold, RobertGoldgirsh, KiraMemon, SarfrazSteinberg, Seth M.Liewehr, DavidPeaceman, DanielWilder, JenniferBryant, KellyFowler, Daniel H.Gea-Banacloche, JuanGress, Ronald E.Pavletic, Steven Z.
- [40] ABO blood group incompatibility as an adverse risk factor for outcomes in patients with myelodysplastic syndromes and acute myeloid leukemia undergoing HLA-matched peripheral blood hematopoietic cell transplantation after reduced-intensity conditioningTRANSFUSION, 2016, 56 (02) : 518 - 527Hefazi, MehrdadLitzow, MarkHogan, WilliamGastineau, DennisJacob, EapenDamlaj, MoussabHashmi, ShahrukhAl-Kali, ArefPatnaik, Mrinal M.